A five-member union Health Ministry team has arrived here to assist investigations into the death of eight infants, allegedly after administration of pentavalent vaccine, officials said Sunday.
The team of paediatricians, headed by Dr. N.K. Arora, arrived here Saturday on a three- day visit.
Dr. Muneer Masoodi of Srinagar's G.B. Pant hospital said the team would assist investigations into the death of infants following administration of the vaccine given to protect infants from hepatitis-B, diphtheria, tetanus, pertussis and Hib (haemophilus influenzae type-b).
Eight infants died in the Kashmir valley last week allegedly following administration of pentavalent vaccine in various hospitals.
Masoodi told IANS that two infants died Oct 10 after being given the vaccine. Six infants allegedly collapsed after the vaccination was administered to them in various district hospitals.
"The infants developed vomiting and severe allergic reaction which are very difficult to control after administration of pentavalent vaccine," he said.
The local doctors association has demanded a ban on pentavalent vaccine in the state, but it can only be done through an order of the union health and family welfare department, said the doctor.
Pentavalent vaccine, also known as Easy-Five, is given to protect infants from hepatitis-B, diphtheria, tetanus, pertussis and Hib (haemophilus influenzae type-b).
Baldev Sharma, director family welfare Jammu and Kashmir said that since the launch of the pentavalent vaccine in the state many vials of the vaccine had been administered to children for protection from these diseases, but no adverse reactions was reported till now.
The director said a detailed investigation has been ordered into these allegations and the probe would be completed within one week.
No decision could be taken on banning the vaccine till the completion of probe, said Sharma.
Parents have been agitating following the death of the infants.
"I will not take my daughter for any vaccination unless the controversy is resolved," said Bashir Ahmad, father of a two-year-old.
Official sources said the pentavalent vaccine was first introduced in December 2011 in Tamil Nadu and Kerala and later in Jammu and Kashmir, Goa, Gujarat, Haryana, Pondicherry and Karnataka.
Pentavalent vaccine was introduced to replace the traditional DPT vaccine administered to infants as protection against diphtheria, pertussis and tetanus.
According to a PIL filed in the Supreme Court against the use of the vaccine, the pentavelent vaccine has been banned or was not being used in European countries, Japan, the UK, Canada, and the US.
The PIL also said that Pakistan, Vietnam, Bhutan, and Sri Lanka have stopped using the vaccine after reports of serious allergic reactions and even deaths.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
